Published recommendations underscore the breadth of nasal high flow therapy application
Data from hundreds of controlled trials have been consolidated into clinical practice guidelines and recommendations.
Review guidelines below
Research interest in NHF is increasing. Over the past decade >350 publications per year (on average) have been cataloged on
PubMed
.
A significant number of controlled trials, systematic reviews and meta-analyses are included.
Medical societies around the world are now in a position to create recommendations that may change clinical practice.
Clinical applications/ scenarios
AARC
Guideline 2021
AARC:
Piraino et al. Management of Adult Patients With Oxygen in the Acute Care Setting. Respir Care. 2021 Nov 2:respcare.09294. doi: 10.4187/respcare.09294. Epub ahead of print. PMID: 34728574.
https://pubmed.ncbi.nlm.nih.gov/34728574/
ESICM
Guideline
2020
ESICM:
Rochwerg et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020 Dec;46(12):2226-2237. doi: 10.1007/s00134-020-06312-y. Epub 2020 Nov 17. PMID: 33201321; PMCID: PMC7670292.
https://pubmed.ncbi.nlm.nih.gov/33201321/
ERS
Guideline
2022
Oczkowski et al.
ERS
clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2022 Apr 14;59(4):2101574. doi: 10.1183/13993003.01574-2021. PMID: 34649974.
https://pubmed.ncbi.nlm.nih.gov/34649974/
SSC
Guideline 2021
Evans et al.
Surviving sepsis campaign:
international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2. PMID: 34599691; PMCID: PMC8486643.
https://pubmed.ncbi.nlm.nih.gov/34599691/
WHO
Guideline 2022
Clinical management of COVID-19: Living guideline, 23 June 2022. Geneva: World Health Organization; 2022 (WHO/2019-nCoV/Clinical/2022.1). Available from:
https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2022-1/ [Accessed 12 September 2022]
ACP
Guideline 2021
Qaseem et al. Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the
American College of Physicians.
Ann Intern Med. 2021 Jul;174(7):977-984. doi: 10.7326/M20-7533. Epub 2021 Apr 27. PMID: 33900796. https://pubmed.ncbi.nlm.nih.gov/33900796/
https://pubmed.ncbi.nlm.nih.gov/33900796/
TSANZ
Guideline 2022
Barnett et al.
Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults
: 'Swimming between the flags'. Respirology. 2022 Apr;27(4):262-276. doi: 10.1111/resp.14218. Epub 2022 Feb 17. PMID:
35178831. https://pubmed.ncbi.nlm.nih.gov/35178831/
JARDS Guideline 2022
Tasaka et al. ARDS Clinical Practice Guideline 2021 committee from the
Japanese Society of Intensive Care Medicine, the Japanese Respiratory Society, and the Japanese Society of Respiratory Care Medicine.
ARDS Clinical Practice Guideline 2021. J Intensive Care. 2022 Jul 8;10(1):32. doi: 10.1186/s40560-022-00615-6. PMID: 35799288; PMCID: PMC9263056.
https://pubmed.ncbi.nlm.nih.gov/35799288/
PRIMARY SUPPORT - MEDICAL
Patients with:
Acute respiratory failure (ARF)
General recommendations for the delivery of supplemental oxygen forpatients who require oxygen (AARC).
Aim for SpO2 range of 94–98% for most of hospitalized patients (included critically ill patients) ---- Aim for 88–92% for patients with COPD ---- Aim for 88–95% for patients with ARDS ---- Consider early initiation of NHF. RECOMMENDATION
based on the collective experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Acute respiratory distress syndrome (ARDS)
ARDS (Joint committee of 3 Japanese societies)
We suggest conducting non-invasive respiratory support (NPPV, HFNC) instead of conventional oxygen therapy
as an initial respiratory management for adult patients with acute respiratory failure suspected of having ARDS if there are no contraindications for non-invasive respiratory support or if organ failure other than respiratory failure is absent. NPPV (weak recommendation/moderate certainty of evidence: GRADE 2B). HFNC (weak recommendation/moderate certainty of evidence: GRADE 2B).Recommendation (CQ 16)
https://pubmed.ncbi.nlm.nih.gov/35799288/
Acute
hypoxemic
respiratory failure (AHRF)
Acute hypoxemic respiratory failure (ESICM):
NHF is preferred to conventional oxygen therapy (COT)
for patients with hypoxemic respiratory failure. STRONG RECOMMENDATION
https://pubmed.ncbi.nlm.nih.gov/33201321/
Acute hypoxemic respiratory failure (ERS):
NHF is preferred to COT or NIV
in patients with acute hypoxemic respiratory failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Acute hypoxemic respiratory failure (ACP):
NHF is preferred to NIV
in patients with AHRF. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33900796/
Oxygen delivery (TSANZ):
hNHF-O2 may be used in patients with acute, severe, hypoxaemic respiratory failure (Grade B)
35178831. https://pubmed.ncbi.nlm.nih.gov/35178831/
Acute
hypercapnic
respiratory failure
Acute hypercapnic respiratory failure (ERS):
Trialling NIV prior to use of NHF
in patients with COPD or acute hypercapnic respiratory failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Sepsis-induced AHRF
Hospitalized patients with severe or critical COVID-19 and acute hypoxaemic respiratory failure (WHO):
use [NHF] rather than standard oxygen therapy. CONDITIONAL RECOMMENDATION. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2022-1
Patients with severe or critical COVID-19
Recommendations regarding ventilation (SSC):
NHF is preferred to NIV
in patients with sepsis-induced hypoxemic respiratory failure. WEAK RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34599691/
Patients who are immunocompromised with AHRF
Immunocompromised
(
AARC):
Either NHF or COT may be used
in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
PRIMARY SUPPORT - SURGICAL
Low risk post-operative patients
Post‑operative (ERS):
Either NHF or COT can be used
in post-operative patients at low risk of respiratory complications. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
High risk post-operative patients
Post‑operative (ERS)
:
Either NHF or NIV
can be used in postoperative patients at high risk of respiratory complications. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
High risk post-cardiothoracic surgery patients
Post-operative (ESICM):
NHF is preferred to COT
in high risk and/or obese patients undergoing cardiac or thoracic surgery to prevent respiratory failure in the immediate postoperative period. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
PRE-ESCALATION SUPPORT
Pre-oxygenation for peri-intubation patients
Peri-intubation (ESICM):
NO RECOMMENDATION is made regarding the use of NHF in the
peri-intubation
period. NHF
during intubation
should be continued for patients who are already receiving NHF. CONTINUE NHF.
https://pubmed.ncbi.nlm.nih.gov/33201321/
DE-ESCALATION SUPPORT
Post-extubation
Post‑extubation (AARC)
NHF is preferred to COT
immediately post-extubation in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Post-extubation respiratory failure (ESICM):
NIPPV is preferred to NHF in patients who would normally be extubated to NIPPV. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Post‑extubation (ACP):
NHF is preferred to COT
in patients with post-extubation AHRF. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33900796/
Low risk, extubated patients
Post‑extubation (ERS):
HFNC over COT in non-surgical patients at low risk of extubation failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
High risk, extubated patients
Post-extubation respiratory failure (ESICM):
NHF is preferred to COT
following extubation in patients with any high-risk feature who were intubated for >24 hours. . CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Post‑extubation (ERS):
NIV is preferred to NHF in non-surgical patients at high risk of extubation failure, unless NIV is contra-indicated. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
COMPLEMENTARY RESPIRATORY SUPPORT
NIV-rested AHRF patients
Breaks from NIV (ERS):
NHF is preferred to COT
during breaks from NIV in patients with acute hypoxemic respiratory. failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
PROPHYLACTIC RESPIRATORY SUPPORT
Patients requiring oxygen for any reason
14.
General recommendations for the delivery of supplemental oxygen for patients who require oxygen (AARC).
Aim for SpO2 range of 94–98% for most of hospitalized patients (included critically ill patients) ---- Aim for 88–92% for patients with COPD ---- Aim for 88–95% for patients with ARDS ---- Consider early initiation of NHF. RECOMMENDATION
based on the collective experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
27.
Avoid escalation (AARC)
NHF is preferred to COT
to avoid escalation to NIV or IV in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Latest Flow Matters Edition
Clinical Practice guidelines
Download PDF for an overview of this page
References and recommendations
Acute hypoxemic respiratory failure (ESICM):
NHF is preferred to conventional oxygen therapy (COT)
for patients with hypoxemic respiratory failure. STRONG RECOMMENDATION
https://pubmed.ncbi.nlm.nih.gov/33201321/
Peri-intubation (ESICM):
NO RECOMMENDATION is made regarding the use of NHF in the
peri-intubation
period. NHF
during intubation
should be continued for patients who are already receiving NHF. CONTINUE NHF.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Post-extubation respiratory failure (ESICM):
NIPPV is preferred to NHF in patients who would normally be extubated to NIPPV. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Post-operative (ESICM):
NHF is preferred to COT
in high risk and/or obese patients undergoing cardiac or thoracic surgery to prevent respiratory failure in the immediate postoperative period. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Acute hypoxemic respiratory failure (ERS):
NHF is preferred to COT or NIV
in patients with acute hypoxemic respiratory failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Acute hypercapnic respiratory failure (ERS):
Trialling NIV prior to use of NHF
in patients with COPD or acute hypercapnic respiratory failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Post‑extubation (ERS):
HFNC over COT in non-surgical patients at low risk of extubation failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Post‑operative (ERS):
Either NHF or COT can be used
in post-operative patients at low risk of respiratory complications. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Breaks from NIV (ERS):
NHF is preferred to COT
during breaks from NIV in patients with acute hypoxemic respiratory. failure. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Recommendations regarding ventilation (SSC):
NHF is preferred to NIV
in patients with sepsis-induced hypoxemic respiratory failure. WEAK RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34599691/
Avoid escalation (AARC):
NHF is preferred to COT
to avoid escalation to NIV or IV in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Post‑extubation (AARC)
NHF is preferred to COT
immediately post-extubation in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Immunocompromised
(
AARC):
Either NHF or COT may be used
in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
General recommendations for the delivery of supplemental oxygen for patients who require oxygen (AARC).
Aim for SpO2 range of 94–98% for most of hospitalized patients (included critically ill patients) ---- Aim for 88–92% for patients with COPD ---- Aim for 88–95% for patients with ARDS ---- Consider early initiation of NHF. RECOMMENDATION
based on the collective experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Acute hypoxemic respiratory failure (ACP):
NHF is preferred to NIV
in patients with AHRF. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33900796/
Post‑extubation (ACP):
NHF is preferred to COT
in patients with post-extubation AHRF. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33900796/
Oxygen delivery (TSANZ):
hNHF-O2 may be used in patients with acute, severe, hypoxaemic respiratory failure (Grade B)
35178831. https://pubmed.ncbi.nlm.nih.gov/35178831/
Post‑operative (ERS)
:
Either NHF or NIV
can be used in postoperative patients at high risk of respiratory complications. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Post-extubation respiratory failure (ESICM):
NIPPV is preferred to NHF in patients who would normally be extubated to NIPPV. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
ESICM:
Rochwerg et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020 Dec;46(12):2226-2237. doi: 10.1007/s00134-020-06312-y. Epub 2020 Nov 17. PMID: 33201321; PMCID: PMC7670292.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Oczkowski et al.
ERS
clinical practice guidelines: high-flow nasal cannula in acute respiratory failure. Eur Respir J. 2022 Apr 14;59(4):2101574. doi: 10.1183/13993003.01574-2021. PMID: 34649974.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Evans et al.
Surviving sepsis campaign:
international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-1247. doi: 10.1007/s00134-021-06506-y. Epub 2021 Oct 2. PMID: 34599691; PMCID: PMC8486643.
https://pubmed.ncbi.nlm.nih.gov/34599691/
AARC:
Piraino et al. Management of Adult Patients With Oxygen in the Acute Care Setting. Respir Care. 2021 Nov 2:respcare.09294. doi: 10.4187/respcare.09294. Epub ahead of print. PMID: 34728574.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Qaseem et al. Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the
American College of Physicians.
Ann Intern Med. 2021 Jul;174(7):977-984. doi: 10.7326/M20-7533. Epub 2021 Apr 27. PMID: 33900796. https://pubmed.ncbi.nlm.nih.gov/33900796/
https://pubmed.ncbi.nlm.nih.gov/33900796/
Barnett et al.
Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults
: 'Swimming between the flags'. Respirology. 2022 Apr;27(4):262-276. doi: 10.1111/resp.14218. Epub 2022 Feb 17. PMID:
35178831. https://pubmed.ncbi.nlm.nih.gov/35178831/
Post-extubation respiratory failure (ESICM):
NHF is preferred to COT
following extubation in patients with any high-risk feature who were intubated for >24 hours. . CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/33201321/
Avoid escalation (AARC)
NHF is preferred to COT
to avoid escalation to NIV or IV in patients who require supplemental oxygen. RECOMMENDATION based on scientific experience.
https://pubmed.ncbi.nlm.nih.gov/34728574/
Tasaka et al. ARDS Clinical Practice Guideline 2021 committee from the
Japanese Society of Intensive Care Medicine, the Japanese Respiratory Society, and the Japanese Society of Respiratory Care Medicine.
ARDS Clinical Practice Guideline 2021. J Intensive Care. 2022 Jul 8;10(1):32. doi: 10.1186/s40560-022-00615-6. PMID: 35799288; PMCID: PMC9263056.
https://pubmed.ncbi.nlm.nih.gov/35799288/
ARDS (Joint committee of 3 Japanese societies)
We suggest conducting non-invasive respiratory support (NPPV, HFNC) instead of conventional oxygen therapy
as an initial respiratory management for adult patients with acute respiratory failure suspected of having ARDS if there are no contraindications for non-invasive respiratory support or if organ failure other than respiratory failure is absent. NPPV (weak recommendation/moderate certainty of evidence: GRADE 2B). HFNC (weak recommendation/moderate certainty of evidence: GRADE 2B).Recommendation (CQ 16)
https://pubmed.ncbi.nlm.nih.gov/35799288/
Post‑extubation (ERS):
NIV is preferred to NHF in non-surgical patients at high risk of extubation failure, unless NIV is contra-indicated. CONDITIONAL RECOMMENDATION.
https://pubmed.ncbi.nlm.nih.gov/34649974/
Prior to ETT
(Joint committee of 3 Japanese societies)
(CQ 18) We suggest conducting HFNC over tracheal intubation as an initial respiratory management for adult patients with acute respiratory failure suspected of having ARDS if there are no contraindications for non-invasive respiratory support or if organ failure other than respiratory failure is absent (weak recommendation/moderate certainty of evidence: GRADE 2B).
https://pubmed.ncbi.nlm.nih.gov/35799288/
`
Hospitalized patients with severe or critical COVID-19 and acute hypoxaemic respiratory failure (WHO):
use [NHF] rather than standard oxygen therapy. CONDITIONAL RECOMMENDATION. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2022-1
Clinical management of COVID-19: Living guideline, 23 June 2022. Geneva: World Health Organization; 2022 (WHO/2019-nCoV/Clinical/2022.1). Available from:
https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2022-1/ [Accessed 12 September 2022]
View references
Subscribe to receive updates related to NHF clinical practice guidelines
Email Address:
*
Country/Region:
*
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo (Dem. Republic)
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard and McDonald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Island of Man
Israel
Italy
Ivory Coast
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea (Democratic Republic of)
Korea (Republic of)
Kosovo
Kuwait
Kyrgyz Republic
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldavia
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Macedonia
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua-New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Re union
Romania
Russian Federation
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and South Sandwich Islands
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
USA
Uzbekistan
Vanuatu
Vatican (Holy See)
Venezuela
Vietnam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe
I consent to Fisher & Paykel Healthcare keeping me informed about new F&P products, clinical updates, events and promotions on Adult Respiratory Care
Subscriptions:
Adult Respiratory Care
Enter security code:*
Comms Medium:
WEB
Interaction Type:
PM-627834_b (page updated 28thSept22)
Adult Respiratory
Therapies
Optiflow Nasal High Flow therapy
Invasive Ventilation
Noninvasive Ventilation
Products
F&P Visairo RT075
Nivairo RT045 Full Face NIV Mask
Nivairo RT047 Full Face NIV Mask
Nivairo+ RT055
Nivairo+ RT056
Nivairo+ RT057
F&P Visairo RT076
F&P Visairo RT077
FreeMotion™ RT041
FreeMotion™ RT042
FreeMotion™ RT043
850 System for Optiflow
Airvo 2 AirSpiral Tube
Airvo™ 2 System
Airvo™ 2 System
Evaqua Technology
F&P 850 System
F&P 850 System
F&P 950 System
F&P 950 System for Invasive Ventilation
Nivairo RT046 Full Face NIV Mask
Optiflow + Nasal Cannula
Optiflow+ Tracheostomy Interface
Search
Login
Products
Products
AIRVO System
Optiflow Therapy
Devices and Humidifiers
All Hospital Products
Our Company
Our Company
About Us
Careers
Contact Us
Sustainability
Education
Optiflow Nasal High Flow therapy
Practice Guidelines
FAQs
FAQs
What is nasal high flow, aka HFNC, therapy? (7 key facts that set it apart)
How quickly does nasal high flow work?
Does Optiflow Nasal High Flow therapy provide positive pressure/PEEP?
Does nasal high flow increase the risk of healthcare worker infection?
Are there published protocols for Nasal High Flow therapy?
All FAQs
Flow Matters
Flow Matters
High flow guidelines and recommendations (May 2021)
COVID-19 (Feb. 2022)
Mechanisms of Action
Optiflow Nasal High Flow therapy
Practice Guidelines
FAQs
FAQs
What is nasal high flow, aka HFNC, therapy? (7 key facts that set it apart)
How quickly does nasal high flow work?
Does Optiflow Nasal High Flow therapy provide positive pressure/PEEP?
Does nasal high flow increase the risk of healthcare worker infection?
Are there published protocols for Nasal High Flow therapy?
All FAQs
Flow Matters
Flow Matters
High flow guidelines and recommendations (May 2021)
COVID-19 (Feb. 2022)
Mechanisms of Action
We value your privacy. Our websites and applications use cookies to function properly and securely.
De-identified Information, as described in our Global Privacy Statement, may be collected and used to support the performance of these sites, and to provide you with a better user experience. Cookie information is not used to promote personalised content on our websites. To learn more about how we use cookies, including examples, go to our
Global Privacy Statement
.
Close
Search
Search
Common search terms
Sleep Apnea Masks
Optiflow™
myAIRVO 2 User Instructions
Contact Us
Common product searches
AIRVO™ 2
myAIRVO™ 2
F&P Eson™ 2 Nasal Mask
F&P Simplus™ Full Face Nask
CPAP Devices
Select your region
:
Australia
Brazil
Canada
Canada (français)
中国
Deutschland
España
Italian
France
India
日本
한국
New Zealand
Россия
United Kingdom
United States
You are on our IN website
Go to US website
Stay on the IN website